Home PBLA
0.265
  Price7.91%   +0.0194
 
loading
Revenue
loading
Net Income
loading
Cash Flow
loading
EPS
loading
Debt to Equity Ratio
loading
Panbela Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics Inc. in December 2020. Panbela Therapeutics Inc. was founded in 2011 and is based in Waconia, Minnesota.
Cap:    |  Volume (24h):